Derek Rapp - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Derek Rapp’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Patient Care,
- Health Care,
- Wellness,
- Women Founded,
- Enterprise Software,
- Fundraising,
- Investment Management,
- Healthcare Innovation,
- Strategic Partnerships,
- Life Science,
- Engineering,
- Portfolio Management,
- Medical Technologies,
- Venture Fundraising,
- Finance,
- Biotechnology,
- Medical Devices,
- Drug Development,
- Electronic Health Records (EHR),
- Health and Hospital Services,
- Clinical Trials,
- Health Diagnostics,
- Founder-Led VC Investments,
- Medical,
- B2B,
- Therapeutics,
- Media and Entertainment,
- Pharmaceuticals,
- Risk Management
Social media:
Past investments:
- Genoa Pharmaceuticals
- Spruce Biosciences
- OncoResponse
- Lutonix
- Standard Bariatrics
- Smart Wires
- Amplyx Pharmaceuticals
- Arch Oncology
- Venture Med Group
- Auxeris Therapeutics
- Kereos
- Mirum Pharmaceuticals
- InterVene
- Conforma Therapeutics
- Tryton Medical
- Salient Surgical Technologies
- Adarza BioSystems
- Excaliard Pharmaceuticals
- MacroGenics
- CardiaLen
- Monsanto Company
- Allakos
- ZS Pharma
- Accumetrics
- Securus Medical Group
- IDEV Technologies
- Tioma Therapeutics
- Reneo Pharmaceuticals
- NexRay
- Cabrellis Pharmaceuticals
- Good Therapeutics
- Xilio Therapeutics
- Avalyn Pharma
- Scout Bio
- Lyric Pharmaceuticals
- WeedOut
- Calypso Medical
- Velocimed
- Lumena Pharmaceuticals
- Otonomy
- Neuros Medical
Investor Profile
Derek Rapp is a Venture Capital, Syndicate, Private Equity Firm, Investor based in St. Louis, Missouri, United States with a diverse investment portfolio that includes companies such as Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix, Standard Bariatrics, Smart Wires, Amplyx Pharmaceuticals, Arch Oncology, Venture Med Group, Auxeris Therapeutics, Kereos, Mirum Pharmaceuticals, InterVene, Conforma Therapeutics, Tryton Medical, Salient Surgical Technologies, Adarza BioSystemsExcaliard Pharmaceuticals, MacroGenics, CardiaLen, Monsanto Company, Allakos, ZS Pharma, Accumetrics, Securus Medical Group, IDEV Technologies, Tioma Therapeutics, Reneo Pharmaceuticals, NexRay, Cabrellis Pharmaceuticals, Good Therapeutics, Xilio Therapeutics, Avalyn Pharma, Scout Bio, Lyric Pharmaceuticals, WeedOut, Calypso Medical, Velocimed, Lumena Pharmaceuticals, Otonomy, Neuros Medical, . Over time, Derek Rapp has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Derek Rapp is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Wellness, Women Founded, Enterprise Software, Fundraising, Investment Management, Healthcare Innovation, Strategic Partnerships, Life Science, Engineering, Portfolio Management, Medical Technologies, Venture Fundraising, Finance, Biotechnology, Medical Devices, Drug Development, Electronic Health Records (EHR), Health and Hospital Services, Clinical Trials, Health Diagnostics, Founder-Led VC Investments, Medical, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals, Risk Management may find it worthwhile to explore potential connections with Derek Rapp, as their portfolio suggests a familiarity and interest in this area.
Understanding Derek Rapp’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
